Experiences of cancer immunotherapy with immune checkpoint inhibitors (ExCIm)—insights of people affected by cancer and healthcare professionals: a qualitative study protocol

INTRODUCTION: There is a global interest in cancer immunotherapy. Clinical trials have found that one group, immune checkpoint inhibitors (ICIs), has demonstrated clinical benefits across various cancers. However, research focused on the experiences of people affected by cancer who have undergone th...

Descripción completa

Detalles Bibliográficos
Autores principales: Jennings, Stephen, Anstey, Sally, Bower, Janet, Brewster, Alison, Buckman, John, Fenlon, Deborah, Fitzsimmons, Deborah, Watts, Tessa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8162091/
https://www.ncbi.nlm.nih.gov/pubmed/34045214
http://dx.doi.org/10.1136/bmjopen-2020-043750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8162091/
https://www.ncbi.nlm.nih.gov/pubmed/34045214
http://dx.doi.org/10.1136/bmjopen-2020-043750

Ejemplares similares